Nick Hart
Direttore/Membro del Consiglio presso ProSpect Pharma, Inc.
Profilo
Nick Hart is currently a Director at ProSpect Pharma, Inc. He was previously the President at Hemcon Medical Technologies, Inc. from 2011 to 2012 and the Chief Financial Officer at Neuro3D SA.
Posizioni attive di Nick Hart
Società | Posizione | Inizio |
---|---|---|
ProSpect Pharma, Inc.
ProSpect Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services ProSpect Pharma, Inc. provides drug designing services. It develops and markets and uses advanced technologies and products for the Life Science industries, particularly those related to drug design, vaccine development and metabolic studies. The company was founded in 2004 and is headquartered in Baltimore, MD. | Direttore/Membro del Consiglio | 31/05/2010 |
Precedenti posizioni note di Nick Hart
Società | Posizione | Fine |
---|---|---|
Hemcon Medical Technologies, Inc.
Hemcon Medical Technologies, Inc. Medical DistributorsDistribution Services Hemcon Medical Technologies, Inc. develops, manufactures, and markets technologies to control bleeding and infection resulting from trauma or surgery. Its solutions include military, emergency and trauma, dental, hemodialysis center, sports medicine, EMS, Cardiac Cath, IR and electrophysiology, wound debridement, occupational healthcare, and wilderness medicine solutions. The company was founded by William Wiesmann, Kenton Gregory, and Simon McCarthy in 2001 and is headquartered in Portland, OR. | Direttore Finanziario/CFO | - |
Neuro3D SA
Neuro3D SA Pharmaceuticals: OtherHealth Technology Neuro3d SA develops pharmaceutical products to treat the central nervous system. Neuro3d has a full pipeline of innovative compounds with new mechanisms of action that have the potential to overcome the limitations of current drug therapies. It leads compound, the atypical antipsychotic ocaperidone, is being investigated in two international double-blind Phase II trials for treatment of schizophrenia. The company was founded in November 2000 and is headquartered in Mulhouse, France. | Direttore Finanziario/CFO | - |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Neuro3D SA
Neuro3D SA Pharmaceuticals: OtherHealth Technology Neuro3d SA develops pharmaceutical products to treat the central nervous system. Neuro3d has a full pipeline of innovative compounds with new mechanisms of action that have the potential to overcome the limitations of current drug therapies. It leads compound, the atypical antipsychotic ocaperidone, is being investigated in two international double-blind Phase II trials for treatment of schizophrenia. The company was founded in November 2000 and is headquartered in Mulhouse, France. | Health Technology |
ProSpect Pharma, Inc.
ProSpect Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services ProSpect Pharma, Inc. provides drug designing services. It develops and markets and uses advanced technologies and products for the Life Science industries, particularly those related to drug design, vaccine development and metabolic studies. The company was founded in 2004 and is headquartered in Baltimore, MD. | Commercial Services |
Hemcon Medical Technologies, Inc.
Hemcon Medical Technologies, Inc. Medical DistributorsDistribution Services Hemcon Medical Technologies, Inc. develops, manufactures, and markets technologies to control bleeding and infection resulting from trauma or surgery. Its solutions include military, emergency and trauma, dental, hemodialysis center, sports medicine, EMS, Cardiac Cath, IR and electrophysiology, wound debridement, occupational healthcare, and wilderness medicine solutions. The company was founded by William Wiesmann, Kenton Gregory, and Simon McCarthy in 2001 and is headquartered in Portland, OR. | Distribution Services |
- Borsa valori
- Insiders
- Nick Hart